Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples